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f%&fiws. T&is was a prospective, randomized, contmlled 
stmdy designed to determine tbe e&et of resistance exercise 
training on bone mfMulism in heart traasplant mcipieats. 
B&nwnd. Osteoporosis fkqmntly complicates heart trans- 
plantation. No preventative strategy is genera& acceptrd for 
glecorortirdd-luducc bcme loss. 
Merhdv. Sixteen q ak beart transplant recipients were ran- 
domly a!dsigmd to a resistance CXerCk! group that traiwd for 6 
months (IUUIII [*SD] age 56 f 6 years) or a control gmup (mean 
age 52 f 10 yean) tbat did not perform resistance exercise. Bone 
mineral density (BMD) of the total body, femor II& and lumbur 
spine (L2 to W) was measured by dualeuergy X-my absorptiom- 
etq hefore aad 2 months afker tm?splmtatlw and after 3 and 6 
months of resistance exe&e or a consul perid. The exe&e 
mgiws consisted of lumbar extensiun exe&e (MfdX) per- 
lbwcd 1 day/week and variable resistance exetises (Nautilus) 
performed 2 day&e&. Each exercise consisted of one rd of 10 to 
IS repetitions perfurmrd to vuiiGuea1 fatigue. 
&a&s. Pmtraasplsntation baseline values for q$onal BMD 
Osteoporosis frequently complicates heart transplantation. Ac- 
celerated bone loss occurs early in the postoperative period 
and appears to be directly associated with glucocorticoid 
therapy (l-5). Heart transplant recipients receiving long-term 
glucocorticoids present a distinctive clinical picture, including 
centripetal obesity with peripheral subcutaneous fat atrophy, 
thinning of the skin with increased fragility and ecchymoses. 
muscle weakness and fluid retention. However, bone dcminer- 
alization with resulting vertebral compression fractures is the 
most incapacitating sequela of steroid therapy. Significant 
vertebral bone loss is observed in up to 97% of heart transplant 
recipients (2), and radiologic evidence of fractures, occurring 
early in the postoperative period. is reported in up to 44% (4). 
The potential reversibility of glucocorticoid-induced bone 
loss is an imponant issue. However, no preventative strategy is 
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did not direr in the control and training groups. Bone mineral 
density of the total body, femur neck and lumhar vertebra (L2 to 
WI were significantly decreased below baseline at 2 manths alter 
transplantation in both the cuntml (-33 f l.3%, -4.5 2 2.m. 
-12.7 f 6.2%. respectively) and training gmups (-2.9 f 1.196, 
5.9 5 3.296, - I41 f 3.18, respectively). Six months of resistance 
exercise mstored BMD of the whule hndy, kmur neck and lumbar 
vertebra to within 1%. I.% and 3.6% uf prctransplantation levels, 
respectively. Bone mineral density of the coutrul group remained 
un&nged fmm the 2-month posttransplantation levels. 
Ccmclusionv. Within 2 months after heart transplantatiua, 
-3% of whole-body BMD Is lost, mostly doe to decmases in 
trabeculsr hone (- 12% to -IS% of lumbar vertebra). Six months 
of ~sistance exercise, cunsisting of luw back exercise that isulates 
the lumbar spine and a regimen of variable resistance exercises, 
mtows BMD toward pretransplaatation levels. Oar msalts sug- 
gest that resistance exercise Is osteogenic and should be initiated 
early after heart transpbmtation. 
(I Am Cd Cadiaf 1994;28:1471-7) 
generally accepted. Calcium supplementation. bisphosphonate 
agents. esrrogenic and androgenic hormones and calcitonin 
have all been used to prevent glucocorticoid-induced osteopo- 
ros%, but they have failed to prevent bone mineral loss after 
heart transplantation (3,s). Bone mineral density (BMD) in 
heart transplant recipients remains significantly below age- 
matched norms. and bone mineral levels do not indicate any 
recovery toward preoperative levels in patients up to 36 
months after transplantation (3.5). 
The purpose of this study was to determine the effect of 
resistance exercise training on defective bone metabolism ii; 
heart transplant recipients. Under normal circumstances, the 
strain or mechanical load placed on bone helps determine its 
structural integrity (6-8). Thus, we hypothesized that resis- 
t:ina exercise might effect suilicient adaptation in the adult 
skeleton.to increase bone mass. Much of the evidence suggest- 
ing a beneficial effect of resisiance exercise on the skeleton 
arises’from abundant cross-sectional studies. Indeed, the ma- 
.jority .of these studies show that resistance training is associ- 
ated with high BMD (6-g). We previously found (9) that 6 
months of resistance exercise increased BMD of the lumbar 
spine in the elderly, and another recent longitudinal study (10) 
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also reported that 4 months of resistance exercise in middle- 
aged and older men was associated with increased BMD and 
bone remodeling. However, these relations have not been 
studied in organ transplant recipients receiving long-term 
glucocorticoids. In the present study. we prospectively deter- 
mined BMD in heart transplant candidates before transplan- 
tation and longitudinally tracked their changes in BMD at 
intervals after transplantation. 
Methods 
Subjects. The descriptive characteristics of the heart trans- 
plant recipients are presented in Table 1. Sixteen male patients 
listed with the United Network for Organ Sharing as ortho- 
topic heart transplant candidates were recruited. The patients 
were randomly and prospectively assigned either to a training 
group that would participate in a program of resistance 
exercise after transplantation or to a control group that would 
not perform specitic resistance exercises. All the heart trans- 
plant recipients participated in postoperative walking pro- 
grams that were comparable in intensity and duration, but only 
the training group performed specific resistance exercises. 
All the heart transplant recipients had biatrial anastomosis 
at the time of transplantation and were receiving standard 
triple-drug immunosuppressive therapy with cyclosporine. 
prednisone and azathioprine. Whole-blood cyclosporine 
trough levels, calculated as an average of four determinations 
over 8 months after transplantation, were similar in the 
training ([mean -tSDj 249 2 18 @ml) and control (256 2 
26 @ml) groups. Three transplant recipients in the training 
group and three in the control group were receiving supple- 
mental calcium throughout the study (900 t 225 mg/24 h). 
Serum creatinine and blood urea nitrogen (BUN), indexes of 
renal function, were similar in both groups (training group: 
Table 1. Descriptive Characteristics of Heart Transplant Recipients 
in Control irnd Training Groups* - 
Conlrol Group Tiaining Group 
(n = R) (n = 8) 
(mean ? SD) (mean z SD) 
Age W 52 f 10 5h ? 6 
Height (cm) 17329. 172+S 
Weight (kg)t SS?ll 78 Ic H 
Waiting list (wk) 262 17 21 2 13 
‘There were no significant differences between groups at baseline. tBody 
weight at prctransplanlatioh bone scan. 
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1 .S -c 0.3 and 26 ? 8 mg/dl. respectively:‘control group: 1.7.‘? 
0.4 and- 29 t Y mg/dl. respectively) at 6 months after trans- 
plantation. No heart trairsplant recipient had evidence of 
atherosclerotic disease. and none had any evidence of cardiac 
allograft vascular disease. The protocol was approvea by the 
institutional review board for the protection of human’subjects 
at the University of Florida College of Medicine, and all 
subjects provided written informed consent to participate in 
the study. 
Glucocorticoid therapy. Heart transplant recipients at our 
institution receive 1.000 mg of methylprednisolone (Solu- 
Medrol) intravenously during the transplantation surgery and 
375 mg/24 h of methylprednisolone intravenously on the first 
postoperative day. Methylprednisolone is reduced to 
250 mg124 h on the second postoperative day and to 
I25 mgG4 h on the third postoperative day. Oral prednisone 
(I mgntg body weight per day) is initiated on the fourth 
postoperative day. During the first 6 weeks after transplanta- 
tion. the daily prednisone dose is tapered by 10 mg each week 
in transplant recipients who remain rejection free. The daily 
prednisone dose is further reduced by 5 mg after the h-week 
biopsy and by 5 mg after the B-week biopsy. Thereafter, in the 
absence of rejection, the daily prednisone dose is decreased by 
2.5 mg every 2 weeks to a target dose of 10 mg/day at 20 weeks 
after transplantation. Further prednisone reduction is not 
attempted until 1 year after transplantation. Episodes of acute 
rejection. as determined by routine slirvcillance endomyocar- 
dial biopsy, are treated with enhanced immunosuppression, 
including increased doses of intravenous methylprednisolone 
or oral prednisone. 
Bone mineral density. Total body and regional BMD, bone 
mineral content and total body calcium were assessed nonin- 
vasively using a dual-energy X-ray absorptiometer (DXA) 
(Lunar Radiation). Subjects were placed in a supine position 
or on their side while the X-ray scanner performed a series of 
transverse scans, moving from top to bottom of the region 
being measured at l-cm intervals. Three separate DXA scans 
were performed: 1) total body scan with the subject supine; 2) 
lateral lumbar spine scan with the subject lying on the left side 
against a cushion that kept the hips flexed at a yo” angle while 
the scanner moved from the top of the L2 vertebra to the 
bottom of the L3 vertebra; 3) hip scan with the subject supine 
while the scanner moved across the right hip, providing 
information on the femur neck. Quality control of the DXA 
machine was performed daily by scanning an anthropomorphic 
phantom supplied by the manufacturer. We previously dem- 
onstrated (11) that regional BMD, bone mineral content and 
total body calcium measurements with this technique are 
highly reliable, and are associated with ~5% variability when 
subject positioning is carefully standardized. 
‘All subjects completed a total of forrr DXA scans. A 
pr&ransplantation DXA scar. wzs performed while subjects 
were heart transplant candidates. The second DXA scan was 
pedormed 2 months after transplantation and just before 
initiation of a resistance training program. The DXA bone 
scans were repeated aft& 3 and 6 months of resistance exercise 
JAK Vol. 28. No. 6 
Nowmher IS. IWb:I ,7J-7 
. 
or a bnirol peri xl. Thus. the final DXA scan was performed 
8 n;onths after Tardiac transplantation. 
Resistance exercise training. The training group began 
sup&vised resistance exercise at 2 months after transplantaticn 
and continued to exercise for a 6-month period. The training 
regimen consisted of two components: 1) lumbar extensor 
training 1 day/week on a MedX lumbar extension machine; and 
2) upper and lower body resistance training 2 days/week using 
Nautilus and MedX variable resistance machines. All training 
sessions involved one transplant recipient supervised by at 
least two exercise specialists. Before resistance exercise ses- 
sions, seated blood pressure and pulse rate measurements 
were recorded and were followed by 5 min of low intensity 
walking on a treadmill. A single set consisting of 10 to 15 
repetitions was completed for each exercise. The initial train- 
ing resistance represented 50% of one repetition maximum. 
The subjects were not permitted to exceed 15 repetitions. 
Rather, when 15 repetitions were successfully achieved, the 
resistance was increased by 5% to 10% at the next training 
session. Thus, the exercise prescription strived to have subjects 
use the greatest resistance possible to complete 15 repetitions. 
The following exercises were performed in order: lumbar 
extension, duo-decline chest press, knee extension, pullover, 
knee flexion, triceps extension, biceps flexion, shoulder press 
and abdominals. Special precautions were taken to ensure 
adequate maintenance of blood pressure in preload-dependent 
cardiac denervated heart transplant recipients. Upper body 
exercises were alternated with lower body exercises in an 
attempt to prevent blood pooling. Symptomatic subjects 
walked 2 min between exercises or performed standing calf 
raises. All subjects concluded each training session with a 
5 min cool-down walk at low intensity on the treadmill. 
The frequency of lumbar training for this study was based 
on previous research (12) that demonstrated that MedX 
lumbar training once a week is as effective as training two or 
three times a week for increasing lumbar extension strpngth. 
Lumbar extension training required subjects to sit in the 
lumbar extension machine with their knees positioned so that 
the femurs were parallel to the seat. The subjects were secured 
in place by femur, pelvic and thigh restraints that stabilized the 
pelvis. A head rest was adjusted to the ltvel of the occipital 
bone for comfort and support. This stabilization procedure has 
been previously described (12). 
Statistical analysis. Descriptive characteristics were com- 
pared between groups using analysis of variance. Analysis of 
covariance. with repeated measures was used to analyze the 
temporal pattern of BMD, body mineral content and total 
bone calcium before and after transplantation. When a signif- 
icant group by time, interaction was observed, within-group 
comparisons between time points and between-group compar- 
isons at each time point were done using analysis of covariance 
with contrast analysis for obtaining appropriate post hoc 
custom hypothesis tests. All statistical analyses were performed 
using the SAS statistical program (SAS Institure Inc.). An 
alpha level of p I 0.05 was required for statistical significance. 
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Table 2. Fncidence of Acute Rejection and Okccorticoid 
Treatment in Control and Resistance Trainkg Groups 
Methylprcdnis&ne. IV 
1 OD X 3 days g 
500 QD x 3 da\% mg 
Prcdnisnnc. oral: 
100 mg X 3days 
wilh rapid taper 
Total treated episodes’ 
Control Group Train& Group 





‘p 2 0.05. control versus mined group. IV = inbavenous: QD = every day. 
Results 
Allograft rejection. Tablp 2 details the incidence of acute 
rejection episodes during the study and the glucocorticoid 
treatment regimens. Acute allograft rejection was determined 
by endomyocardial biopsy and graded using the International 
Society for Heart and Lung Transplantation (ISHLT) system. 
We enhanced immunosuppression only for ISHLT grade 3A or 
3B rejection (Table 2). No patient failed to respond to 
corticosteroid therapy, and none had evidence of “humoral 
rejection,” or hemodynamic compromise. There were 11 epi- 
sodes of acute rejection in the control group and 9 in the 
training group (p 5 0.05). 
Bone mineral density. Absolute values for regional BMD 
in the control and training groups are presented in Table 3. 
Results of the BMD scans are expressed as grams hydroxyap- 
atite divided by the projected area in square centimeters 
(g/cm’). Pretransplantation values for total hody BMD. femur 
neck BMD, lumbar vertebral body BMD (L2 to L3) and 
lumbar vertebra middle BMD (L2 to I.3) were not significantly 
different (p 2 0.05) between the control and training groups. 
The temporal pattern of relative changes in total body 
I3MD and femur neck BMD (percent change from pretrans- 
plant baseline) is shown in Figure 1. Total body BMD de- 
creased significantly below pretransplantation values at 2 
months after transplantation in both the control (-3.3,~ 
1.3%) and training groups (-2.9 t: 1.1%). Six months of 
resistance exercise training restored total body BMD to within 
1% of pretransplantation levels in the training group; the 
control group continued to lose total body BMD at 3 (-5.8 2 
25%) and 6 months (-6.9 2 3.7%). Femur neck BMD was 
signifirantly diminished below baseline at 2 months after 
transplantation in both the control (-4.5 2 2.8%) and training 
groups (-5.9 -C 3.2%). However, femur neck BMD was 
restored to within 1.9% of pretransplantation levels after 6 
months of resistance exercise in the training group. In contrast, 
BMD diminished further at 3 (-6.3 2 1.5% below baseline) 
and 6 months (-7.2 ~-3.7%) in the control group. 
The evolution of relative changes in BMD for the lumbar 
vertebral body and lumbai vertebral middle are shown in 
Figure 2. At 2 months after transplantation, lumbar BMD (L2 
and U) was markedly decreased in the vertebral body and the 
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Table 3. km Mineral Dexity Values of Total Body. Femur Neck. Lumbar Vertebral Body and Lumbar Vcrtshral Midsection and Bone 
.~Mincnl Conrcnt and Total Boric Calcium Values for Resistance Training and Control Groups -- 
&IIIC \linciA Dsnsi::. ($‘ck)’ 
Lumlw Vcrtchral Lumbar Vcrtcbral Btmc Sfincral Ttrtal Bow 
&xl! Midwlitrn Conknt Calcium 
Group Total Body Femur Nccb (12 IO 1~3) (12 10 I.3) lg) (g) 
Conlrol In = S) 
PrcTk I .IIU :7 0.1~13 O.l)hS c ll.OSI 0.x17 I! ll.(W/ 11.77,s 5 II.I!w ?97P.3 ‘2 lJ4.5 I Ih2.Y z? h7.S 
PllSfTS I. lfbl z ll.03’i ll.‘CI ? ll.117ht ll.7lh 2 Il.lls7t Il.677 f O.llS?t X7.Y + I N.Yi lirj3.s = hi.?: 
3 mo I.134 f u.lus: 11.9tu e n.ns!i ll.667 z lI.ll6lf 11.631 r OM5; 2707.9 t l3S.,Si 1075.4 lr hi3 
6 mo l.l?ll ? o.ll.56: lI.SYS 2 I).w4: O.hX3 + Ni)7ni lI.MH + 0.07s~ 3n9.1 % 13x.4: 1lIM.R z 67.9t 
Training (n = 8) 
PrcTx I ,“S I o.osn m-L 1.031 T III!!9 U.XZH I 0. I 11 U.768 5 lJ.IlN 31ir).J 2 :01.5 I171.0 z 63.8 
PostTs 1.193 5 0.077: II.972 + Il.oxs: (I.701 T I).lIM: IMSl z O.lb9f 29-ul.9 2 xl..sv I l(l3.1 + 76.6; 
3 mo I.196 ? lUl79t* 0.9sfl ? Il.lW 11.72x E Il.(ItwtI: Il.672 + ll.IWht~ 194S.h 2 lYh.r* I I I!.5 c 47.9tt 
6 mo I2lh ? I,.lls4$ 1.1112 2 ll.l171$ II.SocJ : Il.IIS5~ 11.740 i 0.073~ 3030.6 ? IsI.6:~ I I.ul.-l ” -wt$ 
___. 
‘Scanr arc cnprrwd as gram, hydrtqapalik dirirlcd h! pnjsckd ;1rcii in aquarc ccntimctcrs &km’). fp 5 II.05 vcrw huliw tnnaplanktion when pakt was 
placcd nn donor organ wailing lisl (PrcTx). $p c 11.115. Training vcrw Control group. Dak~ prcscnbxl arc mean value ‘_ SD. Lumbar Vcrkkal Body = Arc vcrlehnl 
pcrimckr. PLLITX = 2 monlhs ;rftcr ~mnsplantation: 3 mo = ;ifrcr 3 months of rchistencc Iraining: 6 mtr = ;lfkr h mnnlhs of reaiskmcc Wining. 
vcrtcbral middle in both thr control (-IX? + 5.5% and 
-12.7 3 6.2%) and training groups (-14.9 2 4.4% and 
-14.8 ? 3.19). The control group had further significant (p I 
0.05) reductions in lumbar vertebral BMD at 3 months and 
demonstrated little remineralization at the conclusion of the 
study. Indeed. lumbar BMD I~cls at 3 and 6 months of the 
control period were not signiticLntly different in the control 
group and appeared to plateau at levels that were lh% below 
prctransplantation baseline levels. In contrast, specific lumbar 
extension exercise I day/week for 6 months was singularly 
effective in promoting remineralization of the lumbar vertebra 
in the training group. The BMD of the lumbar vertebral body 
and the lumbar vertebral middle were restored to within 2.0% 
arrd 3.6%. respectively, of pretransplantation levels. 
Body mineral content and total bone calcium. Absolute 
values for body mineral content (g) and total bone calcium (g) 
in the control and training groups are presented in Table 3. 
Pretransplantation values for body mineral content and total 
bone calcium were not significantly different (p 2 0.05) 
behvcen the control and training groups. 
The relative changes in body mineral content and total bone 
calcium after transplantation (percent change from pretrans- 
plant baseline) are presented in Figure 3. Similar decreases in 
body mineral content were recorded at 2 months after trans- 
plantation in the control (-5.1 t 1.2% from baseline) and 
training groups (-5.4 2 2.4% from baseline). Body mineral 
content levels remained sappressed in the control group 
(-6.9 t 3.3%) but returned to within 2.4% of baseline levels 
in the training group after 6 months of resistance exercise. 
Total bone calcium alsd decreased dramatically in the early 
postdperative period in both the control (-5.9 t 1.1% from 
baseline) ,and training groups (-5.8 2 1.9% from baseline), 
but improvement in total bone calcium was observed only in 
the group that trained. Body mineral content and total bone 
calcium in the control group were not significantly different 
between 3 and 6 months of the control period. 
Discussion 
Principal findings. To our knowledge, this prospective, 
controlled study is the first to provide quantitative data on the 
efficacy of resistance exercise training as a therapy for defective 
bone metabolism in heart transplant recipients. The evolution 
of axial and appendicular bone mass was determined from 
DXA scans performed before transplantation, 2 months after 
transplantation and after 3 and 6 months of a resistance 
exercise program or a control period. Our results demonstrate 
that regional bone demineralization occurs within 2 months of 
heart transplUntation and is characterized by a rapid early 
phase and a plateau phase after -5 months. Our results also 
indicate that BMD losses from compartments with trabecular 
bone, such as the clinically important lumbar spine, are 
proportionately greater than BMD losses from regions with 
cortical bone. The BMD of the lumbar vertebral body was 
diminished by 12.2% and 14.9% in the control and training 
groups, respectively, at only 2 months after transplantation. 
The main finding of this study is that a 6-month program of 
monitored resistance exercise, consisting of a specific low back 
exercise that isolates the lumbar spine and a regimen of 
variable reistancc exercises fctr the total body, restores re- 
gional BMD toward pretransplantation levels in heart trans- 
plant recipients despite continued immunosuppression with 
glucocortic&ds. In contrast, regional BMD in the control 
group did not indicate any statistically significant recovery 
toward pieoperative levels by 8 months after transplantation. 
Bone mineral density in heart transplant candidates. 
Other studies have reported diminished BMD in heart trans- 
plint recipients, but it was unclear whether postoperative 
osteoporosis was a consequence of heart transplantation and 
immunosuppressive agents or simply a continuation of preex- 
isting osteopenia. engendered by chronic heart failure (4,5). 
Our results suggest that regional BMD is reasonably well 
preserved in heart transplant candidates before heart trans- 
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Fire 1. Changes (A) in total body and femur neck BMD at 2 months 
after heart transplantation (PostTx) and after 3 and 6 months of a 
rcsistancc cxrrcisc program or a control period. Data arc mean 
value: 2 SEM. ‘p 5 0.05 versus pretranspl?ntation [PreTx) value. tp c 
0.05 training versus control group. 
plantation. Whole-body BMD levels recorded before trans- 
plantation compared favorably with age-matched norms in 
both the control (97.3% of norm) and training groups (98.5% 
of norm), indicating that a relatively small amount of bone 
mineral loss had occurred before heart transplantation. Femur 
neck BMD assessed before transplantation also compared 
favorably with age-matched norms in both the control (96% of 
norm) and training groups (97% of norm). Unfortunately, 
age-matched norms for BMD in the lateral view of the lumbar 
spine were not available from the manufacturer of our DXA 
machine, and comparisons were not possible. 
In contrast, significant bone mineral loss reportedly occurs 
in kidney transplant candidates before kidney transplantation 
(13). However, these data should not be generalized to other 
solid-organ transplant groups because preoperative bone loss 
in kidney transplant candidates is most likely related to the 
..-+c-pasts in parathyroid hormone and reductions in &rum 
1,2Sdihydroxyvitamin D. known to occur with renal failure. 
Although cyclosporine does cause a variable decline in renai 
function in most heart transplant recipients after transplanta- 
tion, the relatively modest renal compromise seen in these 
patients does not usually lead to dramatic loss of trabecular 
bone. 
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Figulp 2. Changes in lumbar vertchral body and middle BMD at 1 
mcwhs :rfter heart transplantation and after 3 and 6 months oi a 
resistance cxcrcir program or a control pcricti. Da!a are mean 
value 2 SEM. *p < 0.05 versus pretransplantation value. tp 5 0.05 
[raining vcrws control group. Symbols and abbreviations as in Figure 1. 
Glucocorticoid eliects. The administration of glucocorti- 
coids (methylprednisolone:. prednisonc) is almost certainly the 
major factor in the rapid loss of BMD. Both indirect and direct 
indexes of skeletal metabolism implicate long-term glucocor- 
ticoid therapy in bone demineralization. Osteocalcin. an index 
of bone formation/bone turnover. has been shown (14-17) to 
be decreased by as much as 50% in patients receiving long- 
term glucocorticoid therapy. Direct histologic evidence of 
diminished bone formation is also demonstrated in 
glucocorticoid-treated patients (18). 
Glucocorticoids alter vitamin D metabolism and decrease 
net intestinal calcium absorption while increasing urinary 
excretion of calcium, resulting in a negative calcium balance 
(19). This negative balance leads to secondary hyperpara- 
thyroidism, as evidenced by elevated parathyroid hormone 
(PTH) levels in healt transplant recipients receiving glucocor- 
ticoids (4). However, it seems unlikely that glucocurticoid- 
induced osteoporosis in heart transplant recipients is due 
solely to secondary hyperparathyroidism. Excess FIH usually 
elicits increased compensatory new bone formation coupled 
with the increased bone resorption. In contrast, histomorplm+ 
metric and calcium kinetic studies indicate that new bone forma- 
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Figure 3. Changes in body mineral content and total bone calcium at 
1 months after heart transplantation and after 3 and 6 months of a 
resistance exrrcise program or a control period. Data arc mean 
value 2 SEM. *p I 0.05 versus pretransplantation value. tp 5 0.05 
training group versus control group. !+mbols and abbreviations as in 
Figure I. 
tion is decreased, whereas bone resorption is enhanced in 
glucocorticoid-induced osteoporosis (20). Thus, glucocorticoid- 
induced osteoporosis is characterized by both accelerated bone 
loss and inhibition of new bone iormation. Additionally, excess 
ITH usually does not cause disproportionate losses of trabecular 
bone (20). However, as our data clearly demonstrai.:, tclbecular 
bone loss is indeed a prominent characteristic of bone deminer- 
alization after heart transplantation, suggesting that abnormal 
skeletal metabolism in heart transplant recipients ii mediated by 
glucocort!coid therapy. 
Strategies to prevent osteoporosis. Dictaly calcium supple- 
ments fail to prevent furth:r loss of BMD (23). Intramuscular 
synthetic salmon calcitonin (50 to 100 IUi24 h) ,and testoster- 
one (100 mg every 10 days) or estrogens (2 mg of 
beta-estradioV24 h or estroderm 0.10 mg twice/week) have also 
been recommended for heart transplant recipients. bui ,they 
failed to prevent bone mineral loss after transplantation, with 
further bone mineral losses ranging from 4% to 10% (2,3). 
BMD levels remain significantly below age-matched norms and 
do not indicate any recovery toward preoperative levels in 
patients up to 36 months after transplantation (2,3). Our 
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results suggest that resistance exercise therapy, as part of a 
strategy to prevent trabecular bone loss rather than ‘to treat 
established osteoporosis, should be initiated promptly after 
heart transplantation. -I-his intervention was safe and not 
associated with any increase in rejection. 
Summary. Within 2 months of successful heart transplan- 
tation, -3% of whole-body BMD is lost, mostly due to losses 
in the trabccular bone compartment (12% to 15% of lumbar 
vertebral BMD). A 6-month program of monitored resistance 
exercise, consisting of a specific low back exercise that isolates 
the lumbar spine and a regimen of variable resistance exercises 
that work all major muscle groups safely, restored regional 
BMD toward pretransplantation levels in heart transplant 
recipients receiving long-term glucocorticoid therapy. How- 
ever, regional BMD in the control group did not indicate any 
recovery toward preoperative levels. Our results suggest that 
resistance exercise therapy, as part of a strategy to prevent 
trabecular bone loss, is osteogenic and should be initiated early 
after heart transplantation. 
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